Academic Journal
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
| Title: | The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study |
|---|---|
| Authors: | Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH |
| Source: | BMC Medicine, 05-11-2008 |
| Publisher Information: | BioMed Central Ltd. |
| Publication Year: | 2008 |
| Collection: | Newcastle University Library ePrints Service |
| Description: | Background: We report age-dependent penetrance estimates for leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's disease (PD) in a large sample of familial PD. The most frequently seen LRRK2 mutation, Gly2019Ser (G2019S), is associated with approximately 5 to 6% of familial PD cases and 1 to 2% of idiopathic cases, making it the most common known genetic cause of PD. Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD. Methods: A sample, including 903 affected and 58 unaffected members from 509 families ascertained for having two or more PD-affected members, 126 randomly ascertained PD patients and 197 controls, was screened for five different LRRK2 mutations. Penetrance was estimated in families of LRRK2 carriers with consideration of the inherent bias towards increased penetrance in a familial sample. Results: Thirty-one out of 509 families with multiple cases of PD (6.1%) were found to have 58 LRRK2 mutation carriers (6.4%). Twenty-nine of the 31 families had G2019S mutations while two had R1441C mutations. No mutations were identified among controls or unaffected relatives of PD cases. Nine PD-affected relatives of G2019S carriers did not carry the LRRK2 mutation themselves. At the maximum observed age range of 90 to 94 years, the unbiased estimated penetrance was 67% for G2019S families, compared with a baseline PD risk of 17% seen in the non-LRRK2-related PD families. Conclusion: Lifetime penetrance of LRRK2 estimated in the unascertained relatives of multiplex PD families is greater than that reported in studies of sporadically ascertained LRRK2 cases, suggesting that inherited susceptibility factors may modify the penetrance of LRRK2 mutations. In addition, the presence of nine PD phenocopies in the LRRK2 families suggests that these susceptibility factors may also increase the risk of non-LRRK2-related PD. No differences ... |
| Document Type: | article in journal/newspaper |
| File Description: | application/pdf |
| Language: | unknown |
| Relation: | https://eprints.ncl.ac.uk/151139; https://eprints.ncl.ac.uk/fulltext.aspx?url=151139/F9C12DDC-1E45-491B-BED2-EF9FE96D23B9.pdf&pub_id=151139 |
| Availability: | https://eprints.ncl.ac.uk/151139 |
| Accession Number: | edsbas.FC81F58E |
| Database: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://eprints.ncl.ac.uk/151139# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.FC81F58E RelevancyScore: 769 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 768.664306640625 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Latourelle+JC%22">Latourelle JC</searchLink><br /><searchLink fieldCode="AR" term="%22Sun+M%22">Sun M</searchLink><br /><searchLink fieldCode="AR" term="%22Lew+MF%22">Lew MF</searchLink><br /><searchLink fieldCode="AR" term="%22Suchowersky+O%22">Suchowersky O</searchLink><br /><searchLink fieldCode="AR" term="%22Klein+C%22">Klein C</searchLink><br /><searchLink fieldCode="AR" term="%22Golbe+LI%22">Golbe LI</searchLink><br /><searchLink fieldCode="AR" term="%22Mark+MH%22">Mark MH</searchLink><br /><searchLink fieldCode="AR" term="%22Growdon+JH%22">Growdon JH</searchLink><br /><searchLink fieldCode="AR" term="%22Wooten+GF%22">Wooten GF</searchLink><br /><searchLink fieldCode="AR" term="%22Watts+RL%22">Watts RL</searchLink><br /><searchLink fieldCode="AR" term="%22Guttman+M%22">Guttman M</searchLink><br /><searchLink fieldCode="AR" term="%22Racette+BA%22">Racette BA</searchLink><br /><searchLink fieldCode="AR" term="%22Perlmutter+JS%22">Perlmutter JS</searchLink><br /><searchLink fieldCode="AR" term="%22Ahmed+A%22">Ahmed A</searchLink><br /><searchLink fieldCode="AR" term="%22Shill+HA%22">Shill HA</searchLink><br /><searchLink fieldCode="AR" term="%22Singer+C%22">Singer C</searchLink><br /><searchLink fieldCode="AR" term="%22Goldwurm+S%22">Goldwurm S</searchLink><br /><searchLink fieldCode="AR" term="%22Pezzoli+G%22">Pezzoli G</searchLink><br /><searchLink fieldCode="AR" term="%22Zini+M%22">Zini M</searchLink><br /><searchLink fieldCode="AR" term="%22Saint-Hilaire+MH%22">Saint-Hilaire MH</searchLink><br /><searchLink fieldCode="AR" term="%22Hendricks+AE%22">Hendricks AE</searchLink><br /><searchLink fieldCode="AR" term="%22Williamson+S%22">Williamson S</searchLink><br /><searchLink fieldCode="AR" term="%22Nagle+MW%22">Nagle MW</searchLink><br /><searchLink fieldCode="AR" term="%22Wilk+JB%22">Wilk JB</searchLink><br /><searchLink fieldCode="AR" term="%22Massood+T%22">Massood T</searchLink><br /><searchLink fieldCode="AR" term="%22Huskey+KW%22">Huskey KW</searchLink><br /><searchLink fieldCode="AR" term="%22Laramie+JM%22">Laramie JM</searchLink><br /><searchLink fieldCode="AR" term="%22DeStefano+AL%22">DeStefano AL</searchLink><br /><searchLink fieldCode="AR" term="%22Baker+KB%22">Baker KB</searchLink><br /><searchLink fieldCode="AR" term="%22Itin+I%22">Itin I</searchLink><br /><searchLink fieldCode="AR" term="%22Litvan+I%22">Litvan I</searchLink><br /><searchLink fieldCode="AR" term="%22Nicholson+G%22">Nicholson G</searchLink><br /><searchLink fieldCode="AR" term="%22Corbett+A%22">Corbett A</searchLink><br /><searchLink fieldCode="AR" term="%22Nance+M%22">Nance M</searchLink><br /><searchLink fieldCode="AR" term="%22Drasby+E%22">Drasby E</searchLink><br /><searchLink fieldCode="AR" term="%22Isaacson+S%22">Isaacson S</searchLink><br /><searchLink fieldCode="AR" term="%22Burn+DJ%22">Burn DJ</searchLink><br /><searchLink fieldCode="AR" term="%22Chinnery+PF%22">Chinnery PF</searchLink><br /><searchLink fieldCode="AR" term="%22Pramstaller+PP%22">Pramstaller PP</searchLink><br /><searchLink fieldCode="AR" term="%22Al-hinti+J%22">Al-hinti J</searchLink><br /><searchLink fieldCode="AR" term="%22Moller+AT%22">Moller AT</searchLink><br /><searchLink fieldCode="AR" term="%22Ostergaard+K%22">Ostergaard K</searchLink><br /><searchLink fieldCode="AR" term="%22Sherman+SJ%22">Sherman SJ</searchLink><br /><searchLink fieldCode="AR" term="%22Roxburgh+R%22">Roxburgh R</searchLink><br /><searchLink fieldCode="AR" term="%22Snow+B%22">Snow B</searchLink><br /><searchLink fieldCode="AR" term="%22Slevin+JT%22">Slevin JT</searchLink><br /><searchLink fieldCode="AR" term="%22Cambi+F%22">Cambi F</searchLink><br /><searchLink fieldCode="AR" term="%22Gusella+JF%22">Gusella JF</searchLink><br /><searchLink fieldCode="AR" term="%22Myers+RH%22">Myers RH</searchLink> – Name: TitleSource Label: Source Group: Src Data: BMC Medicine, 05-11-2008 – Name: Publisher Label: Publisher Information Group: PubInfo Data: BioMed Central Ltd. – Name: DatePubCY Label: Publication Year Group: Date Data: 2008 – Name: Subset Label: Collection Group: HoldingsInfo Data: Newcastle University Library ePrints Service – Name: Abstract Label: Description Group: Ab Data: Background: We report age-dependent penetrance estimates for leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's disease (PD) in a large sample of familial PD. The most frequently seen LRRK2 mutation, Gly2019Ser (G2019S), is associated with approximately 5 to 6% of familial PD cases and 1 to 2% of idiopathic cases, making it the most common known genetic cause of PD. Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD. Methods: A sample, including 903 affected and 58 unaffected members from 509 families ascertained for having two or more PD-affected members, 126 randomly ascertained PD patients and 197 controls, was screened for five different LRRK2 mutations. Penetrance was estimated in families of LRRK2 carriers with consideration of the inherent bias towards increased penetrance in a familial sample. Results: Thirty-one out of 509 families with multiple cases of PD (6.1%) were found to have 58 LRRK2 mutation carriers (6.4%). Twenty-nine of the 31 families had G2019S mutations while two had R1441C mutations. No mutations were identified among controls or unaffected relatives of PD cases. Nine PD-affected relatives of G2019S carriers did not carry the LRRK2 mutation themselves. At the maximum observed age range of 90 to 94 years, the unbiased estimated penetrance was 67% for G2019S families, compared with a baseline PD risk of 17% seen in the non-LRRK2-related PD families. Conclusion: Lifetime penetrance of LRRK2 estimated in the unascertained relatives of multiplex PD families is greater than that reported in studies of sporadically ascertained LRRK2 cases, suggesting that inherited susceptibility factors may modify the penetrance of LRRK2 mutations. In addition, the presence of nine PD phenocopies in the LRRK2 families suggests that these susceptibility factors may also increase the risk of non-LRRK2-related PD. No differences ... – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Format Label: File Description Group: SrcInfo Data: application/pdf – Name: Language Label: Language Group: Lang Data: unknown – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://eprints.ncl.ac.uk/151139; https://eprints.ncl.ac.uk/fulltext.aspx?url=151139/F9C12DDC-1E45-491B-BED2-EF9FE96D23B9.pdf&pub_id=151139 – Name: URL Label: Availability Group: URL Data: https://eprints.ncl.ac.uk/151139 – Name: AN Label: Accession Number Group: ID Data: edsbas.FC81F58E |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.FC81F58E |
| RecordInfo | BibRecord: BibEntity: Languages: – Text: unknown Titles: – TitleFull: The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Latourelle JC – PersonEntity: Name: NameFull: Sun M – PersonEntity: Name: NameFull: Lew MF – PersonEntity: Name: NameFull: Suchowersky O – PersonEntity: Name: NameFull: Klein C – PersonEntity: Name: NameFull: Golbe LI – PersonEntity: Name: NameFull: Mark MH – PersonEntity: Name: NameFull: Growdon JH – PersonEntity: Name: NameFull: Wooten GF – PersonEntity: Name: NameFull: Watts RL – PersonEntity: Name: NameFull: Guttman M – PersonEntity: Name: NameFull: Racette BA – PersonEntity: Name: NameFull: Perlmutter JS – PersonEntity: Name: NameFull: Ahmed A – PersonEntity: Name: NameFull: Shill HA – PersonEntity: Name: NameFull: Singer C – PersonEntity: Name: NameFull: Goldwurm S – PersonEntity: Name: NameFull: Pezzoli G – PersonEntity: Name: NameFull: Zini M – PersonEntity: Name: NameFull: Saint-Hilaire MH – PersonEntity: Name: NameFull: Hendricks AE – PersonEntity: Name: NameFull: Williamson S – PersonEntity: Name: NameFull: Nagle MW – PersonEntity: Name: NameFull: Wilk JB – PersonEntity: Name: NameFull: Massood T – PersonEntity: Name: NameFull: Huskey KW – PersonEntity: Name: NameFull: Laramie JM – PersonEntity: Name: NameFull: DeStefano AL – PersonEntity: Name: NameFull: Baker KB – PersonEntity: Name: NameFull: Itin I – PersonEntity: Name: NameFull: Litvan I – PersonEntity: Name: NameFull: Nicholson G – PersonEntity: Name: NameFull: Corbett A – PersonEntity: Name: NameFull: Nance M – PersonEntity: Name: NameFull: Drasby E – PersonEntity: Name: NameFull: Isaacson S – PersonEntity: Name: NameFull: Burn DJ – PersonEntity: Name: NameFull: Chinnery PF – PersonEntity: Name: NameFull: Pramstaller PP – PersonEntity: Name: NameFull: Al-hinti J – PersonEntity: Name: NameFull: Moller AT – PersonEntity: Name: NameFull: Ostergaard K – PersonEntity: Name: NameFull: Sherman SJ – PersonEntity: Name: NameFull: Roxburgh R – PersonEntity: Name: NameFull: Snow B – PersonEntity: Name: NameFull: Slevin JT – PersonEntity: Name: NameFull: Cambi F – PersonEntity: Name: NameFull: Gusella JF – PersonEntity: Name: NameFull: Myers RH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2008 Identifiers: – Type: issn-locals Value: edsbas Titles: – TitleFull: BMC Medicine, 05-11-2008 Type: main |
| ResultId | 1 |